UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000050114 |
|---|---|
| Receipt number | R000057091 |
| Scientific Title | Efficacy study of health food product |
| Date of disclosure of the study information | 2023/01/23 |
| Last modified on | 2024/01/24 11:08:20 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Efficacy study of health food product
Acronym
Efficacy study of health food product
Scientific Title
Efficacy study of health food product
Scientific Title:Acronym
Efficacy study of health food product
Region
| Japan |
Condition
Condition
Healthy female
Classification by specialty
| Dermatology | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The objective of this study is to evaluate the effect on moisturizing and firmness by visual evaluation and bioinstrumentation when applying the test materials(test ingredient formulation and placebo) for 8 weeks.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Hydration level of stratum corneum: Corneometer
Skin Viscoelasticity: Cutometer :MPA580
Key secondary outcomes
Photographs of facial image (Spots, Skin texture, Wrinkles, and Pores): VISIA Evolution
Photographic Evaluations ( Wrinkles)
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Food |
Interventions/Control_1
Apply the health food product (Pentadecyl-containing Aurantiochytrium oil) once a day for 8 weeks.
Interventions/Control_2
Apply the health food product (placebo) once a day for 8 weeks.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 65 | years-old | >= |
Gender
Female
Key inclusion criteria
(1) Japanese female aged from 30 to 65 years;
(2) Subject who is self-perceived sensitive skin;
(3) Subject who has any concerns about face sagging; and
(4) Subject who is willing to participate in the study and can comply with study requirements.
Key exclusion criteria
(1) Subject who is pregnant or nursing, or is planning to become pregnant or nursing during the study;
(2) Subject who is using any drug, quasi-drug, supplements, or health food products which may affect the evaluation of the study;
(3) Subject who has a food allergy;
(4) Subject who has a skin disorder such as atopic dermatitis;
(5) Subject who is participating in any other clinical trials; and
(6) Subject who otherwise disqualified from participation in the study for any reason at the discretion of the study physician.
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | Kazumi |
| Middle name | |
| Last name | Nozawa |
Organization
Interface, Inc.
Division name
Not applicable
Zip code
010-0001
Address
2-8-1-7, Nakadori, Akita-shi, Akita, 010-0001, Japan
TEL
018-827-7155
kazumi.nozawa@interface-akita.com
Public contact
Name of contact person
| 1st name | Miyuki |
| Middle name | |
| Last name | Kodama |
Organization
Interface, Inc.
Division name
Not applicable
Zip code
010-0001
Address
2-8-1-7, Nakadori, Akita-shi, Akita, 010-0001, Japan
TEL
018-827-7155
Homepage URL
mkodama@interface-akita.com
Sponsor or person
Institute
Interface, Inc.
Institute
Department
Personal name
Funding Source
Organization
Sea Act Co.,LTD
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The ethical committee of Interface, Inc.
Address
2-8-1-7, Nakadori, Akita-shi, Akita, 010-0001, Japan
Tel
018-827-7155
mkodama@interface-akita.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 01 | Month | 23 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
48
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2022 | Year | 12 | Month | 26 | Day |
Date of IRB
| 2023 | Year | 01 | Month | 06 | Day |
Anticipated trial start date
| 2023 | Year | 01 | Month | 10 | Day |
Last follow-up date
| 2023 | Year | 03 | Month | 21 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2023 | Year | 01 | Month | 23 | Day |
Last modified on
| 2024 | Year | 01 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057091
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
